DAY · As filed with the SEC
Dayforce cash flow statement, by quarter
The statement as Dayforce presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Cash Flows · USD
| USD | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024 3 months ended Dec 31, 2024 | Q3 2024 3 months ended Sep 30, 2024 | Q2 2024 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023 3 months ended Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Net (loss) income | — | — | 14,900,000 | — | — | — | 7,100,000 | — |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||
| Deferred income tax benefit | — | — | (18,900,000) | — | — | — | (11,800,000) | — |
| Depreciation and amortization | — | — | 53,900,000 | — | — | — | 48,800,000 | — |
| Amortization of debt issuance costs and debt discount | — | — | 1,100,000 | — | — | — | 1,100,000 | — |
| Loss on debt extinguishment | — | — | 0 | — | — | — | 4,300,000 | — |
| Provision for doubtful accounts | — | — | 3,800,000 | — | — | — | 800,000 | — |
| Net periodic pension and postretirement cost | — | — | 4,800,000 | — | — | — | 2,600,000 | — |
| Share-based compensation expense | — | — | 45,900,000 | — | — | — | 38,000,000 | — |
| Change in fair value of contingent consideration | — | — | — | — | — | — | 0 | — |
| Other | — | — | (100,000) | — | — | — | — | — |
| Changes in operating assets and liabilities, excluding effects of acquisitions: | ||||||||
| Trade and other receivables | — | — | (35,400,000) | — | — | — | (48,100,000) | — |
| Prepaid expenses and other current assets | — | — | (17,100,000) | — | — | — | (13,100,000) | — |
| Deferred sales commissions | — | — | (9,600,000) | — | — | — | (6,300,000) | — |
| Accounts payable and other accrued expenses | — | — | 6,600,000 | — | — | — | (1,800,000) | — |
| Deferred revenue | — | — | (2,600,000) | — | — | — | (2,300,000) | — |
| Employee compensation and benefits | — | — | (17,800,000) | — | — | — | (27,800,000) | — |
| Accrued taxes | — | — | 18,900,000 | — | — | — | 17,800,000 | — |
| Other assets and liabilities | — | — | 1,200,000 | — | — | — | (200,000) | — |
| Net cash provided by operating activities | — | — | 49,600,000 | — | — | — | 9,100,000 | — |
| Cash flows from investing activities | ||||||||
| Purchases of customer funds marketable securities | — | — | (180,000,000) | — | — | — | (139,600,000) | — |
| Proceeds from sale and maturity of customer funds marketable securities | — | — | 86,900,000 | — | — | — | 49,600,000 | — |
| Purchases of marketable securities | — | — | (3,700,000) | — | — | — | (500,000) | — |
| Proceeds from sale and maturity of marketable securities | — | — | 6,800,000 | — | — | — | 1,000,000 | — |
| Expenditures for property, plant, and equipment | — | — | (4,000,000) | — | — | — | (3,500,000) | — |
| Expenditures for software and technology | — | — | (26,100,000) | — | — | — | (24,400,000) | — |
| Acquisition costs, net of cash acquired | — | — | 0 | — | — | — | (173,300,000) | — |
| Net cash used in investing activities | — | — | (120,100,000) | — | — | — | (290,700,000) | — |
| Cash flows from financing activities | ||||||||
| Decrease in customer funds obligations, net | — | — | 334,400,000 | — | — | — | 1,763,500,000 | — |
| Proceeds from issuance of common stock under share-based compensation plans | — | — | 4,400,000 | — | — | — | 15,300,000 | — |
| Taxes paid related to the net share settlement of awards under share-based compensation plans | — | — | (17,100,000) | — | — | — | — | — |
| Repurchases of common stock | — | — | (30,100,000) | — | — | — | — | — |
| Proceeds from debt issuance | — | — | 0 | — | — | — | 650,000,000 | — |
| Repayment of long-term debt obligations | — | — | (1,800,000) | — | — | — | (644,500,000) | — |
| Payment of debt refinancing costs | — | — | (1,200,000) | — | — | — | (11,400,000) | — |
| Net cash used in financing activities | — | — | 288,600,000 | — | — | — | 1,772,900,000 | — |
| Effect of exchange rate changes on cash, restricted cash, and equivalents | — | — | 1,000,000 | — | — | — | (13,500,000) | — |
| Net decrease in cash, restricted cash, and equivalents | — | — | 219,100,000 | — | — | — | 1,477,800,000 | — |
| Cash, restricted cash, and equivalents at beginning of period | 2,341,300,000 | 3,473,000,000 | 3,253,900,000 | 2,077,600,000 | 3,132,200,000 | 4,899,200,000 | 3,421,400,000 | 3,616,300,000 |
| Cash, restricted cash, and equivalents at end of period | 2,444,700,000 | 2,341,300,000 | 3,473,000,000 | 3,253,900,000 | 2,077,600,000 | 3,132,200,000 | 4,899,200,000 | 3,421,400,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.